+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthopedic Soft Tissue Repair - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5304224
The global market for Orthopedic Soft Tissue Repair was estimated at US$8.4 Billion in 2023 and is projected to reach US$12.1 Billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Orthopedic Soft Tissue Repair Market - Key Trends & Drivers Summarized

Why Is Orthopedic Soft Tissue Repair Essential in Treating Sports Injuries and Degenerative Conditions?

Orthopedic soft tissue repair has become critical in treating a wide range of injuries and degenerative conditions, especially as sports participation and physical activity continue to rise globally. Soft tissues, including tendons, ligaments, and cartilage, play an essential role in stabilizing joints and facilitating movement, yet they are highly susceptible to injuries from repetitive motion, trauma, and age-related degeneration.

Injuries to these structures, such as rotator cuff tears, ACL ruptures, and meniscal damage, are common among athletes and active individuals and often require surgical intervention for full recovery. Orthopedic soft tissue repair techniques - ranging from minimally invasive arthroscopic surgeries to more advanced biological therapies - offer effective solutions for restoring function, reducing pain, and preventing long-term damage. By repairing and reinforcing these critical structures, orthopedic soft tissue repair supports patients in regaining mobility, strength, and quality of life.

The rising incidence of sports-related injuries has made orthopedic soft tissue repair a focal point in sports medicine, where quick and effective recovery is essential for athletes and active individuals. Procedures like tendon and ligament reconstruction, cartilage repair, and meniscal repair are widely used to address acute and chronic injuries, allowing patients to return to their activities with reduced risk of re-injury. For example, ACL reconstruction is a common procedure in competitive sports, where knee stability is crucial.

This procedure uses grafts to replace the torn ligament and restore knee function, often enabling athletes to resume their performance levels. Similarly, rotator cuff repair surgeries are frequently performed in individuals who engage in overhead activities, which can lead to tendon wear and tears over time. As sports participation and fitness awareness grow, so does the demand for specialized soft tissue repair techniques that support fast, safe recovery.

In addition to treating sports injuries, orthopedic soft tissue repair is essential in addressing age-related conditions like tendinopathy, degenerative disc disease, and osteoarthritis, which commonly affect older adults. With age, soft tissues lose elasticity and resilience, making them more prone to tears and degeneration. Soft tissue repair techniques, including tendon transfers, cartilage grafting, and minimally invasive arthroscopy, provide effective options for treating these conditions, reducing pain, and restoring mobility. By addressing both acute injuries and chronic degeneration, orthopedic soft tissue repair helps mitigate the impact of aging on joint function and quality of life, positioning it as an essential aspect of comprehensive orthopedic care for people of all ages.

How Are Biological Therapies and Innovations Advancing the Orthopedic Soft Tissue Repair Market?

The orthopedic soft tissue repair market has been significantly influenced by the rise of biological therapies and technological innovations that aim to enhance healing and improve outcomes. Biological therapies, such as platelet-rich plasma (PRP), stem cell therapy, and autologous chondrocyte implantation (ACI), offer new approaches for repairing and regenerating damaged soft tissues. PRP, which involves concentrating platelets from the patient's own blood, is injected into the injured area to promote tissue repair through growth factors. Stem cell therapy uses stem cells to potentially regenerate damaged tissue, offering a promising option for conditions like rotator cuff tears and cartilage damage.

These biologic treatments provide an alternative to traditional repair methods by enhancing the body's natural healing processes, potentially reducing recovery times and improving the quality of tissue repair. As biological therapies gain traction, they are reshaping the soft tissue repair landscape by providing minimally invasive, regenerative options that meet patient demand for faster recovery and reduced scarring.

In addition to biological therapies, innovations in surgical techniques and implant materials have driven advancements in orthopedic soft tissue repair. Arthroscopic surgery, which involves the use of a small camera and specialized instruments, allows surgeons to repair soft tissues through tiny incisions, reducing trauma and accelerating recovery. This technique is commonly used for shoulder, knee, and hip repairs, offering patients shorter hospital stays and quicker returns to activity. Innovations in suture anchors, which are used to reattach soft tissues to bone, have also enhanced the effectiveness of these repairs.

Modern suture anchors are designed for improved fixation strength and bioabsorption, reducing the need for additional procedures. Bioabsorbable anchors and all-suture anchors dissolve over time, minimizing long-term complications and supporting natural healing. As minimally invasive techniques and bio-friendly materials become standard in orthopedic surgeries, these innovations are providing surgeons with better tools to achieve successful and lasting repairs.

Furthermore, tissue engineering and synthetic grafts are emerging as promising solutions for orthopedic soft tissue repair, particularly for complex or large-scale injuries. Synthetic grafts made from materials like polyurethane and polycaprolactone mimic the structure and function of natural tissues, providing scaffolding that supports cell growth and tissue regeneration. For example, in tendon and ligament repairs, synthetic grafts offer an alternative when autografts or allografts are not available, supporting tissue integration and improving joint stability.

Tissue engineering techniques that combine synthetic materials with biologics are also under development, with the aim of creating hybrid grafts that blend the strength of synthetics with the regenerative potential of biological tissues. These advanced materials and techniques provide new options for treating challenging injuries, expanding the scope of soft tissue repair and opening up new opportunities in the orthopedic market.

What Are the Benefits of Orthopedic Soft Tissue Repair for Surgeons and Patients?

Orthopedic soft tissue repair offers numerous benefits for both surgeons and patients, enabling effective treatment of complex injuries while promoting faster and safer recovery. For surgeons, the primary advantage is the ability to restore joint stability and functionality through precise, minimally invasive procedures. Arthroscopic techniques, which allow repairs through small incisions, enable surgeons to visualize and treat damaged tissues with minimal disruption to surrounding structures.

This approach improves surgical precision, reduces the risk of complications, and allows surgeons to address specific injuries without extensive incisions. These minimally invasive techniques are especially valuable in treating common sports injuries, such as ACL tears and rotator cuff damage, where targeted repairs lead to better outcomes and faster patient recovery. By using advanced imaging and specialized tools, surgeons can achieve highly accurate repairs, which is essential for restoring full joint mobility and function.

For patients, orthopedic soft tissue repair provides significant benefits in terms of pain relief, mobility restoration, and long-term joint health. Soft tissue injuries, if left untreated, can lead to chronic pain, joint instability, and functional limitations that affect daily life and physical activity. Repairing damaged tendons, ligaments, and cartilage through soft tissue repair techniques enables patients to regain joint stability, reduce pain, and return to their regular activities.

Procedures such as tendon reconstruction and ligament repair help restore the strength and flexibility of the injured joint, reducing the risk of re-injury and supporting long-term health. For athletes and active individuals, soft tissue repair allows for quicker rehabilitation, enabling them to return to sports and exercise with confidence. Additionally, by addressing these injuries early on, soft tissue repair helps prevent the progression of joint degeneration, which can lead to arthritis and the need for more invasive surgeries later.

Another crucial benefit is the focus on biologic and regenerative approaches, which can enhance healing and reduce recovery times. Biological therapies like PRP and stem cell injections provide patients with options that work alongside the body's natural repair mechanisms, often resulting in less scarring and improved tissue quality. These regenerative techniques are particularly beneficial for patients with high physical demands or those who require a faster recovery, such as athletes or individuals with physically demanding jobs. The use of biologics in soft tissue repair not only supports a more natural healing process but also aligns with the growing demand for minimally invasive, patient-friendly treatments. With advancements in biologic therapies and minimally invasive techniques, orthopedic soft tissue repair offers patients safer, more efficient recovery paths that improve overall treatment experiences and outcomes.

What Is Fueling the Growth in the Orthopedic Soft Tissue Repair Market?

The growth in the orthopedic soft tissue repair market is driven by factors such as the increasing incidence of sports injuries, the aging population, advancements in biologic and minimally invasive therapies, and a growing emphasis on patient-centered outcomes. As sports and recreational activities become more popular worldwide, the incidence of sports-related injuries, such as ACL tears, rotator cuff injuries, and meniscal damage, has risen significantly.

These injuries often require surgical intervention, creating a high demand for specialized soft tissue repair techniques that enable effective, durable solutions. Orthopedic soft tissue repair provides the tools and techniques needed to meet this demand, helping athletes and active individuals recover fully and return to their activities. Additionally, with the increased popularity of fitness and wellness trends, more people are participating in physical activities that increase their risk of soft tissue injuries, further fueling the market demand.

The aging population is another major factor contributing to the growth of the orthopedic soft tissue repair market. As people age, they are more susceptible to degenerative conditions that affect soft tissues, such as tendinopathy, osteoarthritis, and ligament degradation. Older adults often require soft tissue repair procedures to restore mobility, reduce pain, and maintain independence. Procedures like rotator cuff repair and cartilage restoration are particularly common in this demographic, addressing age-related degeneration and helping older individuals stay active. As life expectancy increases, the need for solutions that support joint health and mobility in later years continues to drive demand for soft tissue repair. This trend is expected to grow as healthcare providers and patients prioritize maintaining an active lifestyle and high quality of life throughout aging.

The rise of biologic and minimally invasive therapies has also boosted the orthopedic soft tissue repair market, as these advancements offer less invasive, more efficient treatment options with quicker recovery times. Biological treatments such as PRP and stem cell therapy are increasingly recognized for their potential to enhance soft tissue healing and reduce recovery durations, meeting the expectations of patients seeking modern, regenerative solutions. The expansion of arthroscopic techniques, which allow surgeons to perform precise repairs through small incisions, aligns with the demand for minimally invasive approaches that reduce recovery time and improve patient comfort.

These innovative therapies and techniques not only offer effective results but also appeal to healthcare providers focused on improving patient outcomes. Together, these factors - rising sports injuries, the aging population, and advancements in biologics and minimally invasive surgery - are driving the growth of the orthopedic soft tissue repair market, positioning it as a critical area within modern orthopedic and sports medicine.

Scope of the Study

The report analyzes the Orthopedic Soft Tissue Repair market, presented in terms of market value (US$ Million). The analysis covers the key segments and geographic regions outlined below.

Segments

Procedure (Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy, Other Procedures); Injury Location (Knee, Shoulder, Hip, Small Joints)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cruciate Ligaments Repair Procedure segment, which is expected to reach US$5.6 Billion by 2030 with a CAGR of a 7.0%. The Rotator Cuff Repair Procedure segment is also set to grow at 3.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.3 Billion in 2023, and China, forecasted to grow at an impressive 5.0% CAGR to reach $1.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Orthopedic Soft Tissue Repair Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Orthopedic Soft Tissue Repair Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Orthopedic Soft Tissue Repair Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Orthopedic Soft Tissue Repair Market such as Artelon, Arthrex, ConMed, DePuy Synthes, Integra LifeSciences and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Global Orthopedic Soft Tissue Repair Market report include:

  • Artelon
  • Arthrex
  • ConMed
  • DePuy Synthes
  • Integra LifeSciences
  • JRF Ortho
  • LifeNet Health
  • Medtronic
  • MTF Biologics
  • Parcus Medical
  • RTI Surgical
  • Smith & Nephew
  • Stryker
  • Tissue Regenix
  • Wright Medical
  • Zimmer Biomet

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Orthopedic Soft Tissue Repair - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Sports-Related Injuries Drives Soft Tissue Repair Market
  • Growing Preference for Minimally Invasive Surgeries Sets the Stage for Market Growth
  • Innovations in Biodegradable Implants Propel Demand for Soft Tissue Repair Solutions
  • Increasing Demand for Arthroscopic Procedures Expands Market Potential
  • Advancements in Biomaterials Propel Soft Tissue Repair Technologies
  • Rising Geriatric Population Generates Demand for Soft Tissue Repair Solutions
  • Increasing Use in Rotator Cuff Repair Expands Addressable Market
  • Growing Demand for Cartilage Repair Solutions Drives Market Growth
  • Increasing Investments in Sports Medicine Propel Soft Tissue Repair Demand
  • Soft Tissue Repair Crucial for Treatment of Tendon and Ligament Injuries
  • Use of Soft Tissue Repair in Trauma Surgeries Bodes Well for Market Expansion
  • Demand for Biocompatible Repair Materials Sets the Stage for Market Growth
  • Expanding Applications in Gynecological, and Urological Surgeries
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Cruciate Ligaments Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Rotator Cuff Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Epicondylitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Achilles Tendinosis Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Pelvic Organ Prolapsed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Hip Arthroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 29: World Historic Review for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 30: World 16-Year Perspective for Small Joints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 32: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 33: World 16-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 35: World Historic Review for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 36: World 16-Year Perspective for Shoulder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 37: World Orthopedic Soft Tissue Repair Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 38: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: USA Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: USA 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 41: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: USA Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: USA 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
CANADA
  • Table 44: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Canada Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Canada 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 47: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Canada Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Canada 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
JAPAN
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 50: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Japan 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 53: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Japan Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Japan 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
CHINA
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 56: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: China Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: China 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 59: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: China Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: China 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
EUROPE
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 62: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Europe 16-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 65: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Europe 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Europe 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
FRANCE
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 71: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: France Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: France 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 74: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: France Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: France 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
GERMANY
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 77: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Germany Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Germany 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 80: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Germany Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Germany 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
ITALY
  • Table 83: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Italy Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Italy 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 86: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Italy Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Italy 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 89: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: UK Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: UK 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 92: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: UK Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: UK 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2014, 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned

  • Artelon
  • Arthrex
  • ConMed
  • DePuy Synthes
  • Integra LifeSciences
  • JRF Ortho
  • LifeNet Health
  • Medtronic
  • MTF Biologics
  • Parcus Medical
  • RTI Surgical
  • Smith & Nephew
  • Stryker
  • Tissue Regenix
  • Wright Medical
  • Zimmer Biomet

Table Information